The sources
behind the words.
Primary provider pages for service information. Regulators, guidelines, and human research for the medical context. Each article links the sources it uses.
CoreAge Rx: Sermorelin product page ↗
Live product page; starting price is not a verified checkout total.
CoreAge Rx: About the service ↗
The page discusses GLP-1 services; do not automatically apply those billing terms to sermorelin.
AgelessRx: Sermorelin Injection ↗
Product page includes introductory and recurring price language; check the selected plan.
AgelessRx: Sermorelin Nasal Spray ↗
Different delivery route; injectable evidence is not proof of equivalent nasal outcomes.
IVY RX: Sermorelin Injections ↗
Live retrieval showed a $179 starting figure with use varying; other indexed versions differed.
IVY RX: Sermorelin cost guide ↗
Plan examples can differ from the current product page; not a checkout quote.
Hone Health: Sermorelin Injections ↗
Medication and membership figures are displayed separately.
Strut Health: Injectable Sermorelin Peptide Therapy ↗
Auto-refill starting price; confirm quantity, interval, and total before paying.
Defy Medical: Sermorelin patient handout ↗
Historical vial pricing and pharmacy names; current availability and care fees require confirmation.
Invigor Medical: Sermorelin studies and offering ↗
Public article advertises treatment; current checkout and total costs were not tested.
Invigor Medical: Sermorelin FAQs ↗
Some broad outcome claims go beyond what the evidence establishes.
FDA: Risks of compounded drugs ↗
Explains lack of FDA approval and the risks of poor-quality compounded preparations.
FDA: Compounding questions and answers ↗
Compounded medicines differ from FDA-approved generic drugs.
FDA: 2013 GEREF withdrawal determination ↗
Historical GEREF products were not withdrawn for safety or effectiveness reasons; this does not approve current compounds.
Endocrine Society: Adult growth hormone deficiency ↗
Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
Endotext: Growth Hormone and Aging ↗
Separates hormone and body-composition findings from functional outcomes and long-term unknowns.
Vitiello et al.: GHRH and cognition in older adults ↗
A six-month study in 89 older adults; not evidence of dementia prevention or all current preparations.
HHS: Telehealth licensing across state lines ↗
Licensure options depend on the patient location and state rules.
FSMB: Contact a state medical board ↗
Find the relevant state authority to verify a physician.
NABP: Buy medication safely ↗
Tools for checking online pharmacies and recognizing unsafe sellers.
US Census Bureau: 2025 Gazetteer places ↗
Incorporated places and census-designated places; not a list of clinics or every neighborhood.
FDA: Safely using sharps at home ↗
Sharps handling and disposal; local collection rules vary.
MedlinePlus: Sleep disorders ↗
General sleep disorder education; not a sermorelin efficacy source.
MedlinePlus: Fatigue ↗
Fatigue has many causes that may need evaluation.
MaleMD: Doctor-prescribed sermorelin ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Everlife: Sermorelin GHK ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Eden: Sermorelin injection ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Eden: Sermorelin ODT ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
ReadyRx: Sermorelin ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
ReadyRx: Sermorelin ODT ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Healthon: Sermorelin injection ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Healthon: Sermorelin ODT ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
bmiMD: Sermorelin injection ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Olympia Pharmacy: Compounded sermorelin injection ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Maximus: Sermorelin and aging ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Embody Her Health: Sermorelin ↗
Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
Mayo Clinic: Sermorelin injection information ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
FDA: Bulk drug substances under section 503A ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
FDA: Peptide compounding safety concerns ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
DailyMed: EGRIFTA WR prescribing information ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
NIDDK: Prescription medications for weight management ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
Endocrine Society: Testosterone therapy guideline ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagogues ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
Sinha et al.: Growth hormone secretagogues and male body composition ↗
Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
Nass et al.: MK-677 randomized trial in older adults ↗
Human randomized trial; ibutamoren is not sermorelin.
WADA: 2026 Prohibited List ↗
Sermorelin named under S2.2.4; rules are sport- and year-specific.
HRSA Poison Help: What you can do ↗
US poison-help contact; suspected overdose requires individual assessment.
National Institute on Aging: Aging and alcohol ↗
General older-adult guidance, not a sermorelin interaction trial.
National Institute on Aging: Taking medicines safely ↗
General medication handling and communication guidance.
American Academy of Dermatology: Hair loss diagnosis and treatment ↗
Cause-specific evaluation; not evidence of sermorelin efficacy.
Endocrine Society: Growth and short stature ↗
Pediatric assessment and growth biology; not an adult height-enhancement indication.
Hims: Does sermorelin increase testosterone? ↗
Educational page; does not establish current product availability.
Empower Pharmacy: Sermorelin acetate injection ↗
Pharmacy product page; not a complete care package or checkout quote.
Grant et al.: NAD+ infusion metabolome pilot study ↗
Small IV metabolism study; not proof of anti-aging outcomes or another route.
FDA: Ingredients suitable for sterile compounding ↗
NAD+ quality warning; not a claim that every product is contaminated.
bmiMD help center: Programs offered ↗
Official program listing; current pricing and terms need confirmation.
Lilly: What to know about retatrutide ↗
Checked September 20, 2026; retatrutide remains investigational and is available through clinical trials.
Maximus: Growth hormone peptides ↗
Contains multiple peptide options; prices depend on selected product, dose, state and term. Clinical claims are marketing, not independent comparisons.
Maximus: Sermorelin protocol overview ↗
Sermorelin-specific administration and care information; not independent outcome evidence.
Maximus: Sermorelin prescriptions, refills and shipping ↗
Explains clinician review, pharmacy fulfillment and support roles; not a tested service guarantee.
FDA: Empower Pharmacy warning letter, April 2, 2025 ↗
Facility-specific warning letter following a 2024 inspection. Not a finding about every current sermorelin vial; current corrective-action status was not independently established.
NIDDK: Hypothyroidism ↗
Symptoms, diagnosis and established thyroid treatment; not a sermorelin trial.
NIDDK: Acromegaly ↗
Explains effects of pathological GH excess; does not estimate diabetes risk from prescribed sermorelin.
FDA: Drug interactions, what you should know ↗
General medicine, food and supplement interaction principles, not an exhaustive sermorelin interaction list.
FDA: Managing the benefits and risks of medicines ↗
General questions for evaluating benefit, follow-up and new medicines.
FDA: Safe drug use after a natural disaster ↗
General temperature-exposure guidance. Does not establish a sermorelin stability window or injectable reconstitution method.
IRS: Publication 502, Medical and Dental Expenses ↗
Medical-expense definitions; not an individual insurance or account-eligibility determination.
IRS: Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans ↗
HSA/FSA qualified-expense and recordkeeping rules. Current accessible edition is for 2025; no 2026 numerical limits are inferred.
MedlinePlus: Anaphylaxis ↗
General emergency allergy recognition; not a sermorelin-specific event rate.
CDC: About cellulitis ↗
Skin infection symptoms and when prompt medical attention is needed.
Baker et al.: GHRH and cognitive function, controlled trial (2012) ↗
152 enrolled adults; 20 weeks of tesamorelin, not sermorelin. Cognitive outcomes are not dementia prevention.
GHRH, cognition and brain connectivity: pilot trial (2026) ↗
22 participants and ten weeks of tesamorelin. No significant direct changes in study measures; exploratory analyses do not establish clinical benefit.
Gimme Care: public treatment prices ↗
The homepage has sermorelin-specific price rows alongside GLP-1 information. General GLP-1 terms are not automatically sermorelin terms.
Gimme Care: Sermorelin injection ↗
Product-specific offering; not independent evidence of results or a verified checkout.
Gimme Care: Refund policy ↗
Published cancellation and damaged-product procedures, not a universal legal entitlement or tested refund.
Good Life Meds: Sermorelin ↗
Retrieved promotional prices and conflicting stock labels require checkout confirmation; testimonials include other products.
Good Life Meds: Sermorelin safety information ↗
Provider instructions and warnings; exact pharmacy label and clinician directions remain controlling.
Lavender Sky Health: Sermorelin ↗
Several routes and formulations; not evidence of equivalence across them.
Lavender Sky Health: Treatment plan pricing ↗
Lists quantities and pharmacy-specific prices; not universal monthly rates or a complete care quote.
Lavender Sky Health: Service pricing ↗
Medical service charges must be distinguished from medication charges.
Lavender Sky Health: Prescription summaries ↗
Identifies pharmacy and formulation options; exact prescription and current access need confirmation.
LifeMD: Men’s health program ↗
Contains a sermorelin compounded-product disclosure. Product card and safety text differ on route; no complete sermorelin quote verified.
American Heart Association: Home blood pressure monitoring ↗
General measurement and urgent-response guidance; not a sermorelin trial or an individual blood pressure target.
MedlinePlus: Headache ↗
General headache warning signs and assessment, not a sermorelin-specific risk estimate.
MedlinePlus: Joint swelling ↗
Unexplained joint swelling and fever require clinical attention; does not diagnose drug causation.
NIAMS: Carpal tunnel syndrome ↗
Explains nerve compression symptoms; not a finding that sermorelin caused a reader’s symptoms.
NHLBI: Sleep apnea symptoms ↗
Sleep-related breathing symptoms and evaluation.
NHLBI: Sleep apnea treatment ↗
Established treatment options; not evidence for sermorelin as an apnea treatment.
DEA: Steroids drug fact sheet ↗
Anabolic steroid classification; separate from peptide identity and sporting rules.
Office on Women’s Health: Menopause treatment ↗
Supports symptom-specific menopause care and distinguishes estrogen/progesterone therapy from other hormone pathways. No drug-specific dosing or individual eligibility is inferred.
NHS Specialist Pharmacy Service: Missed or delayed medicine doses ↗
General advice to seek product-specific instructions and avoid doubling a missed dose; not a sermorelin-specific catch-up schedule.
CDC: Signs and symptoms of stroke ↗
Emergency recognition and calling 911; does not establish a sermorelin-related stroke risk.
Nuform Health: sermorelin therapy ↗
Plan figures and product claims; confirm current kit total, fees, and prescription. Checked September 21, 2026.
Nuform Health: care model ↗
General care model; not every fee or service necessarily applies to sermorelin. Checked September 21, 2026.
Nuform Health: refund policy ↗
Published policy, not a tested refund outcome. Checked September 21, 2026.
Ivím Health: sermorelin ↗
Dissolvable product and separate membership price; medication supply period requires confirmation. Checked September 21, 2026.
Ivím Health: membership ↗
General membership features; confirm selected plan inclusions. Checked September 21, 2026.
Ivím Health: refund and returns policy ↗
Current published terms, not an independent service assessment. Checked September 21, 2026.
Ivím Health: compounded sermorelin safety information ↗
General safety disclosure does not establish patient eligibility or a product-specific prescription. Checked September 21, 2026.
DirectMeds: sermorelin product page ↗
Storefront prices and claims differ from some other company pages; obtain a written quote. Checked September 21, 2026.
DirectMeds: sermorelin and tesamorelin offering ↗
Combined marketing page; survey and benefit claims are not independently verified clinical evidence. Checked September 21, 2026.
DirectMeds: Sermorix pricing help ↗
Published bottle prices differ from the storefront; do not assume which applies to a selected order. Checked September 21, 2026.
Brello Health: compounded sermorelin ↗
Product and payment information; page also contains a mismatched semaglutide FAQ. Checked September 21, 2026.
Brello Health: checkout terms ↗
Three-month plan terminology with an 11-week renewal cycle; confirm final checkout terms. Checked September 21, 2026.
Brello Health: refund policy ↗
Published cancellation and replacement conditions; not independently tested. Checked September 21, 2026.
NIAMS: osteoporosis overview ↗
Bone disease and fracture risk; not evidence of sermorelin efficacy. Checked September 21, 2026.
NIAMS: osteoporosis diagnosis and treatment ↗
DXA, fracture assessment, established treatment, and fall prevention. Checked September 21, 2026.
MedlinePlus: memory ↗
Memory concerns have several possible causes and warrant assessment. Checked September 21, 2026.
MedlinePlus: cognitive testing ↗
Screening is part of a clinical assessment, not a self-diagnosis. Checked September 21, 2026.
MedlinePlus: confusion ↗
Sudden confusion requires urgent medical help. Checked September 21, 2026.
FDA: historical GEREF chemistry review ↗
Identifies sermorelin acetate and GRF(1-29)NH2; historical product details are not directions for current compounded preparations. Checked September 21, 2026.
HHS: your medical records ↗
Patient access and correction rights; not a guarantee of prescription transfer or continuation. Checked September 21, 2026.
PubChem / NCI: sermorelin acetate ↗
Acetate salt identity; not proof of interchangeability of finished products. Checked September 21, 2026.
Dawson-Hughes et al.: anamorelin and osteosarcopenia ↗
Different molecule: 26 adults, one year; biomarker changes do not establish fracture prevention by sermorelin. Checked September 21, 2026.
Midi Health: Sermorelin ↗
Checked September 21, 2026. Starting medication price and provider claims; no enrollment or clinical testing.
Midi Health: Insurance and pricing ↗
Self-pay visit rates are separate from medication pricing. Insurance and additional costs depend on the plan.
Midi Health: Sermorelin safety sheet ↗
Provider formulation and safety information, not FDA approval or a personalized prescription.
Get Thin MD: Sermorelin injection program ↗
Checked visible offer and plan controls September 21, 2026; promotions and final checkout can differ.
Get Thin MD: Fulfillment, cancellation, and refund policy ↗
Published subscription terms; weight-loss guarantee specifically concerns named GLP-1 medications.
Get Thin MD: Important safety information ↗
Multi-product safety page; use the sermorelin section rather than other-drug warnings or claims.
PeterMD: Sermorelin ↗
Visible prices are for four and twelve weeks, not calendar months; page lists Alabama and Idaho exclusions.
PeterMD: Refund and auto-bill policy ↗
Published 48-hour cancellation notice for auto-renewing products and 24-hour damaged-product reporting condition; confirm selected-order terms.
Shed: Sermorelin injection ↗
Visible September 21, 2026 page lists $199 per month. Hidden unrelated template content excluded.
Shed: Longevity Daily offer ↗
Introductory sermorelin promotion must be separated from renewal pricing and the GLP-1 weight-loss guarantee.
Shed: Terms and conditions ↗
Multiple product and subscription provisions; confirm agreement applicable to selected sermorelin order.
CoreAge Rx: Current sermorelin offer ↗
Public redirect checked September 22, 2026. Landing page advertises $99 per month and no auto-billing; not a verified patient checkout.
FDA: Q7A good manufacturing practice guidance for active pharmaceutical ingredients ↗
Section 11.4 describes API certificates of analysis. Not a universal patient disclosure rule for compounded finished products.
FDA: Drug quality sampling and testing programs ↗
Illustrates distinct quality tests; does not establish testing of any sermorelin product reviewed here.
FDA: Expiration dates questions and answers ↗
Explains stability, labeled storage, and product-specific extensions; no universal compounded sermorelin lifetime.
USP: Compounded preparation monographs ↗
Canonical page blocked automated retrieval; indexed USP-hosted overview confirms the general BUD definition. No numerical or sermorelin-specific BUD rule is asserted.
FDA: Do not be tempted to use expired medicines ↗
General patient advice; does not quantify the risk from a particular sermorelin vial.
FDA: Understanding drug recalls ↗
Lot matching, risk classifications, and following the actual notice; not a claim about current sermorelin recall status.
FDA: Drug recalls ↗
Public announcements are not a complete inventory of all recalls; consult the FDA Enforcement Report.
FDA: Consumer complaint system and MedWatch ↗
Patient reporting of medication quality problems and adverse events; not an emergency care channel.
FDA: Sharps disposal containers ↗
Container selection and household alternatives where permitted; local disposal rules apply.
FDA: Best way to get rid of used needles and other sharps ↗
Immediate containment, fill level, travel preparation, and community disposal programs.
FDA: Drug disposal questions and answers ↗
Medication take-back is different from sharps collection; confirm accepted items locally.
MedlinePlus: Handling sharps and needles ↗
General sharps handling guidance; follow the container instructions and local disposal rules.
FDA: Know your bulks and excipients suppliers ↗
Ingredient supply-chain guidance; an API certificate does not establish finished-vial quality.
Joi + Blokes: Sermorelin peptide therapy ↗
Visible September 21, 2026 prices: $559 subscription or $699 one-time for twelve weeks. Injections and troches are different routes; state-specific pricing notice appears.
Joi + Blokes: Sermorelin offer ↗
Separate promotional page has different pricing; no universal lowest checkout total is inferred.
Joi + Blokes: Refund and return policy ↗
Published cancellation and refund stages; not a tested customer-service outcome or legal opinion.
Joi + Blokes: Terms of service ↗
Platform, clinician, pharmacy, and subscription roles; pharmacy partners do not identify the dispenser for every order.
Regenics: Sermorelin injection ↗
Dedicated product page says 15 mg, while the kit catalog says 9 mg. Member and subscription-control prices differ; confirm the actual offer and preparation.
Regenics: Membership ↗
Membership fee and medication price are separate; no all-in monthly treatment total is invented.
Regenics: Terms of service ↗
Published plan, consultation, and medication policies require selected-order confirmation.
Brightmeds: Sermorelin summer offer ↗
Visible offer September 21, 2026: $129/month. Older third-party prices and unavailable legacy subdomain were not substituted.
Brightmeds: Special-offer refund and cancellation policy ↗
Current linked policy; no purchase or refund request was tested.
Brightmeds: Special-offer terms ↗
Commercial conditions are not a clinical safety or effectiveness guarantee.
Refills: Sermorelin injection ↗
Product-specific public information; patient-specific price, prescription, and final checkout were not verified.
Refills: Daily health ↗
Multi-product marketing and self-reported outcomes do not establish controlled sermorelin efficacy.
Refills: Pharmacy partners ↗
Named partners need confirmation for the particular product, state, and order.
Refills: Terms and conditions ↗
General service terms may cover different products and plans; confirm applicable agreement.
Refills: Returns ↗
Published return and cancellation information, not an independently tested refund outcome.
American Academy of Dermatology: Hair loss or hair shedding ↗
Explains delayed shedding after stressors; does not establish a sermorelin-specific adverse-event rate.
American Academy of Dermatology: Hair loss causes ↗
Medication and other causes require assessment; do not abruptly stop unrelated prescribed medicines.
American Academy of Dermatology: Managing hair loss ↗
Diagnosis, gentle care, and avoiding unnecessary supplements.
MedlinePlus: Drug allergies ↗
General distinction between allergy and other adverse effects; no sermorelin-specific incidence estimate.
MedlinePlus: Epinephrine injection ↗
Use according to an existing emergency plan and obtain emergency help; not a new prescription or dosing guide.
NIAMS: Sports injury diagnosis, treatment, and steps to take ↗
Diagnosis-specific rehabilitation and return to activity; no endorsement of sermorelin.
Mendias et al. 2020: Growth hormone after ACL reconstruction pilot trial ↗
Nineteen men ages 18–35; recombinant human growth hormone, not sermorelin. Strength findings do not establish broader injury healing.
Endocrine Society: Hormone replacement in hypopituitarism guideline ↗
2016 guideline: diagnostic context, stimulation tests, and GH replacement for proven deficiency. Not approval of compounded sermorelin for aging.
Endocrine Society: Growth hormone deficiency ↗
Childhood and adult disease sections are distinct; adult risk factors and prescribed GH replacement are the relevant material.
Regenics: At-home injection kits ↗
Catalog describes 9 mg while dedicated product page describes 15 mg; confirm the current preparation.
Mochi Health: Sermorelin medication page ↗
Starting medication price plus required membership; injectable product. Checked September 21, 2026.
Mochi Health: Longevity treatment catalog ↗
Membership promotion, renewal price and separate medication charges. Checked September 21, 2026.
Mochi Health: Alternate sermorelin landing page ↗
Older search snapshots list other prices and routes; live browser visit redirects to the current injection page. Checked September 21, 2026.
Mochi Health: Refund policy ↗
Membership and compounded-prescription provisions must be distinguished. Checked September 21, 2026.
Mochi Health: Terms and conditions ↗
General platform terms; confirm the selected membership and prescription agreement. Checked September 21, 2026.
iThriveMD: Sermorelin treatment and pricing ↗
Multi-month figures are monthly equivalents with longer billing intervals; no checkout performed. Checked September 21, 2026.
iThriveMD: 90-day member pricing ↗
Sermorelin add-on requires a qualifying primary plan; displayed promotion is not independently confirmed available. Checked September 21, 2026.
iThriveMD: Current homepage offers ↗
Homepage promotion retains an August 31 end date; do not assume a September review guarantees eligibility. Checked September 21, 2026.
iThriveMD: Return policy ↗
Public policy text and any retrieval limitations are recorded in the batch notes. Checked September 21, 2026.
iThriveMD: Terms of use ↗
Public policy; not a patient-specific contract interpretation. Checked September 21, 2026.
beyondMD: Oral sermorelin program ↗
Capsule offer; not evidence of equivalence to injections or other oral preparations. Checked September 21, 2026.
beyondMD: Sermorelin injections program ↗
Medication pricing and item descriptions; not a clinical product test. Checked September 21, 2026.
beyondMD: Treatment catalog ↗
Catalog starting figures may differ from product-page figures. Checked September 21, 2026.
beyondMD: Refund and cancellation policy ↗
Distinguishes consultation fees, approved medications and pending orders. Checked September 21, 2026.
beyondMD: Non-FDA disclosure ↗
Provider disclosure of compounded product status; FDA sources supply the regulatory context. Checked September 21, 2026.
SynergenX: Sermorelin therapy ↗
Clinic-led consultation model and provider claims; no national recurring medication price established. Checked September 21, 2026.
SynergenX: Special offers ↗
Hormone-test promotion is not a monthly sermorelin medication price. Checked September 21, 2026.
SynergenX: Insurance information ↗
General hormone-care insurance statements do not guarantee sermorelin coverage. Checked September 21, 2026.
SynergenX: Kingwood clinic ↗
One specific listed clinic; does not establish every location offers the same services. Checked September 21, 2026.
FDA: Biotin interference with troponin tests ↗
Some assays are affected; not a universal sermorelin interaction or stop interval.
NIH ODS: Biotin fact sheet ↗
Supplement evidence and assay-dependent laboratory interference.
MedlinePlus: Preparing for a laboratory test ↗
Follow the ordering clinician and laboratory instructions; no self-directed medicine changes.
CDC: Understanding needle fears and phobia ↗
General procedural support; vaccination examples are not sermorelin administration instructions.
CDC: Easy-to-read needle phobia information ↗
Individual coping plans and professional help for severe fear.
Endocrine Society: Lipid management guideline ↗
Recommends against GH replacement solely to lower LDL; not a sermorelin efficacy trial.
TSA: Unused syringes ↗
Airport screening with accompanying injectable medication; not international import authorization.
TSA: Liquid medications ↗
Medically necessary liquid screening; extra screening can apply.
TSA: Disabilities and medical conditions ↗
Medical accessories and cold-pack screening; not storage stability guidance.
CDC: Traveling abroad with medicine ↗
Country-specific restrictions, documentation and travel preparation.
NHLBI: Blood cholesterol treatment ↗
Risk-based treatment and lifestyle changes; no sermorelin recommendation.
NHLBI: Cholesterol causes and risk factors ↗
Several causes of lipid changes, including medical conditions and medicines.
RespondWell: Sermorelin shop offer ↗
Provider offer; first-order and refill amounts differ from another RespondWell page. Checked September 22, 2026.
RWell by RespondWell: Sermorelin plans ↗
Provider offer; prepaid monthly equivalents differ from one-month charges. Checked September 22, 2026.
RWell: Billing and refunds ↗
Public billing policy; read with the selected plan and prescribing decision. Checked September 22, 2026.
RespondWell: Billing and refund policy ↗
Public policy; not a tested cancellation or refund. Checked September 22, 2026.
Concierge MD: Sermorelin service ↗
Public search-accessible service page; direct browser access returned a challenge. Three-month subscription minimum and cross-service wording require clarification. Checked September 22, 2026.
Concierge MD: Sermorelin injection costs ↗
Provider pricing article; not an individualized quote. Checked September 22, 2026.
Concierge MD: San Francisco peptide therapy ↗
Location marketing and subscription FAQ; local service still requires confirmation. Checked September 22, 2026.
Gameday Men’s Health: Sermorelin injections ↗
National service listing; no public medication price identified in the reviewed page. Checked September 22, 2026.
Gameday Men’s Health: Telehealth FAQs ↗
General telehealth arrangements; does not establish sermorelin availability for every location. Checked September 22, 2026.
Gameday Men’s Health: Location finder ↗
Clinic discovery; services are delivered by independently owned and operated clinics. Checked September 22, 2026.
Valhalla Vitality: Sermorelin therapy ↗
Current public listing gates price and full details behind sign-in. No account was created. Checked September 22, 2026.
Valhalla Vitality: Terms and conditions ↗
Platform policies; not a verified sermorelin-specific checkout agreement. Checked September 22, 2026.
Valhalla Vitality: Therapy catalog ↗
Catalog labels subscription availability; no logged-in purchase inspected. Checked September 22, 2026.
FSMB: Information for consumers ↗
Licensure and disciplinary information through state boards and DocInfo. Checked September 22, 2026.
CMS: NPI records and credential limitation ↗
An NPI does not itself validate licensing or credentials. No dataset downloaded. Checked September 22, 2026.
HHS: Telehealth legal considerations ↗
General licensing, consent, and privacy guidance; state-specific verification remains necessary. Checked September 22, 2026.
NIDDK: Keeping kidneys safe with medicines ↗
General kidney disease medication planning, not sermorelin renal dosing guidance. Checked September 22, 2026.
NIDDK: Chronic kidney disease tests and diagnosis ↗
GFR and urine albumin measure different aspects of kidney health. Checked September 22, 2026.
NIDDK: Managing chronic kidney disease ↗
Ongoing kidney care; no evidence of sermorelin benefit or dosing supplied. Checked September 22, 2026.
NIDDK: Treatment for cirrhosis ↗
Medication discussion and disease-specific care; not a sermorelin trial. Checked September 22, 2026.
NIDDK: Diagnosis of cirrhosis ↗
History, blood tests, and imaging; not a home diagnostic checklist. Checked September 22, 2026.
SuperHealthy Rx: official serm offer ↗
Official page read October 4, 2026. Published offer, not independently verified outcomes.
CoreAge Rx: shipping reference and service details ↗
Shipping offer checked October 11, 2026. Customer service and payment details were supplied for this review; no checkout or timed support test was performed.
SuperHealthy Rx: shipping reference and service details ↗
Shipping offer checked October 11, 2026. Customer service and payment details were supplied for this review; no checkout or timed support test was performed.
BRAVO1 Wellness: sermorelin assessment and plan ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
BRAVO1 Wellness: laboratory documentation status ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
FDA determination on discontinued Geref products, March 4, 2013 ↗
Primary reference; does not endorse the reviewed provider.
FDA: Understanding the Risks of Compounded Drugs ↗
Primary reference; does not endorse the reviewed provider.
FDA: Compounding questions and answers ↗
Regulatory context for compounded drugs.
Endocrine Society: Adult growth hormone deficiency ↗
Diagnostic and treatment context for adult deficiency; not an endorsement of wellness prescribing.
System Labs: compounded sermorelin injection ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
System Labs: oral compounded sermorelin ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
System Labs: terms and cancellation stages ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
Hormones and Aging: An Endocrine Society Scientific Statement ↗
Primary reference; does not endorse the reviewed provider.
Velvet Rx: treatment catalog and starting prices ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
Velvet Rx: terms of use and subscriptions ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
Trava: sermorelin product and payment options ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
Trava: prescribing pathway and compounding disclosure ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
Good Life Meds: sermorelin offer and inclusions ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
Good Life Meds: care model and quality statements ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
Shed: sermorelin injection monthly supply ↗
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
IVY RX: current sermorelin injection offer ↗
Rendered offer showed $179 with use-varies wording; extracted legacy price tables were not treated as the current selected plan. Checked October 16, 2026.
IVY RX: weight-care menu ↗
Rendered treatment cards include prescription categories and a separately labeled supplement. Tile amounts do not establish a full selected order. Checked October 16, 2026.
IVY RX: refund policy ↗
No returns stated; contact invitation is not a guaranteed refund. Checked October 16, 2026.
IVY RX: terms of service ↗
Subscription renewal provisions and a defined 15-day refund-request procedure; application to the selected purchase must be confirmed. Checked October 16, 2026.
FDA: Understanding the Risks of Compounded Drugs ↗
Compounding and pharmacy registration do not confer finished-product FDA approval. Checked October 16, 2026.
FDA: concerns with unapproved GLP-1 drugs ↗
Product-specific safety and compounding context; not a provider effectiveness ranking. Checked October 16, 2026.